Terminology Service for NFDI4Health
All terms in MESH
| Label | Id | Description |
|---|---|---|
| Progression-Free Survival | D000077982 | [Length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but the disease does not get worse.] |
| Treatment Outcome | D016896 | [Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.] |
| Survival Analysis | D016019 | [A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.] |
| 3-nitro-2-pentanol | C539264 | |
| 5P12-RANTES | C539265 | |
| 6P4-RANTES | C539266 | |
| poly(1-naphthylamine) | C539267 | |
| 2-N, 6-O-sulfated chitosan | C539268 | |
| XPF protein, Arabidopsis | C539269 | |
| Glutathione Peroxidase Deficiency, Hemolytic Anemia possibly due to | C564217 | |
| Glutathione Reductase, Hemolytic Anemia due to Deficiency of, in Red Cells | C564218 | |
| Maturity-Onset Diabetes of the Young, Type 2 | C564219 | |
| Granulomatous Disease, Chronic, Autosomal Dominant Type | C564210 | |
| Granddad Syndrome | C564211 | |
| Goniodysgenesis-Mental Retardation-Short Stature Syndrome | C564214 | |
| Glyoxalase II Deficiency | C564215 | |
| Shroom1 protein, human | C539270 | |
| SCPL-1 protein, C elegans | C539271 | |
| 2-isonicotinoyl-N-(2-(trifluoromethyl)phenyl)hydrazinecarbothioamide | C539272 | |
| RWJ 800088 | C539273 |